Drug Topics

Independent pharmacies face a new era: Lawsuits, state enforcement, and FDA deadlines are reshaping GLP-1 compounding. Compliance is now critical for survival. Read More: hubs.li/Q047HnnS0 #pharmacy #GLP1

Oral GLP-1 therapies promise easier starts, but true impact depends on bridging support gaps and addressing emotional barriers to adherence. Explore the patient journey: hubs.li/Q047HHtw0 #GLP1 #PatientCare

Only 43% of patients and pharmacists agree on key medication takeaways, highlighting a critical communication gap. It’s time to prioritize interactive, patient-centered counseling. Read More: hubs.li/Q047HHnQ0

Medicare changes and TrumpRx are transforming drug access. Pharmacists now play a vital role in helping patients navigate new payment options and maintain affordable care. Read More: hubs.li/Q047HGNq0

Black and African American women account for 50% of new HIV diagnoses, but pharmacists are key to closing gaps through accessible testing, PrEP/PEP, and adherence support. Read More: hubs.li/Q047HvRw0 #HIV #HealthEquity

Breakthrough for plaque psoriasis: FDA approves Icotyde, the first oral IL-23 receptor blocker, offering biologic-level skin clearance in a daily pill for adults and teens. Read More: hubs.ly/Q047rF0P0 #FDA #Psoriasis #Dermatology #Innovation

New research in 350K+ UK Biobank patients shows eGDR empowers pharmacists to spot cardiometabolic risk early, enabling proactive care before irreversible multimorbidity. Read More: hubs.li/Q047rvPD0

Heightened FDA focus on compounded GLP-1s means pharmacists must know 503A vs 503B rules, avoid brand-name comparisons, and justify batches. Compliance is critical. Read More: hubs.li/Q047rwKk0 #Pharmacy #GLP1 #Compliance #FDA

FDA clears Medtronic’s MiniMed Flex, the smallest, screenless, smartphone-controlled insulin pump for patients as young as 7—a new era in discreet, automated diabetes care. Read More: hubs.li/Q047ry8T0 #Diabetes #MedTech

Pharmacies are navigating shrinking margins and new clinical roles. Can your workflow keep up? Explore strategies for success in a changing landscape: hubs.li/Q047jlfY0 #Pharmacy #Healthcare #Medicare

Semaglutide vs dulaglutide: Both cut A1c in new type 2 diabetes, but semaglutide leads in weight loss (12kg vs 7.5kg), which is key for body composition goals. Read More: hubs.li/Q047jfLY0

New studies reveal no link between prenatal acetaminophen and ADHD/autism after adjusting for genetics. Pharmacists must guide patients on OTCs with evidence-based care. Read More: hubs.li/Q047j76J0 #Pharmacy #WomensHealth

Swift action stopped a 2024 pneumococcal outbreak in an NC prison. PPSV23 vaccination curbed cases in just 5 days, showing that timely vaccination and serotype tracking save lives in high-risk settings. Read More: hubs.li/Q047j6hh0

Pharmacy is at a crossroads: telehealth, PBM reform, and Medicare changes are reshaping the field. Stay ahead by seeing what experts say about the evolving policy landscape. Read More: hubs.li/Q0475bsd0 #Pharmacy #Healthcare

Big news for adolescent HS care: FDA expands secukinumab (Cosentyx) approval to patients 12 and older—the first IL-17A inhibitor for this age group. Read More: hubs.li/Q0475f-N0 #FDA #HidradenitisSuppurativa

As demand for compounded GLP-1 medications surges amid ongoing legal battles and quality concerns, pharmacists must verify supplier credentials, scrutinize certificates of analysis, and source APIs exclusively from FDA-registered facilities. Read More: hubs.li/Q0475fky0

Breakthrough: Incretin-based polyagonists are cutting liver fat by up to 82.7% in trials, outpacing GLP-1s. Pharmacists can drive personalized care for metabolic liver disease. Read More: hubs.li/Q04755Sf0

Berberine is gaining attention as a natural, cost-effective option for metabolic syndrome, showing promise beyond traditional therapies. Explore the latest insights on its clinical potential: hubs.li/Q046VSMq0 #MetabolicSyndrome #Healthcare

Pharmacist-led point-of-care testing is redefining rural health care. 97% of patients report high satisfaction as independent pharmacies are vital diagnostic hubs for underserved areas. Read More: hubs.li/Q046VS9R0 #RuralHealth #PharmacyCare

Surprising new data: Seasoned pharmacists trust AI more than their younger colleagues. Early AI training is key for the next generation. Discover the findings: hubs.li/Q046VCB40 #AIinPharmacy #HealthcareInnovation